Seeing Is Believing
Currently out of the existing stock ratings of Richard Newitter, 290 are a BUY (57.43%), 212 are a HOLD (41.98%), 3 are a SELL (0.59%).
Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 68.32% that have a potential upside of 22% achieved within 183 days.
Richard Newitter’s has documented 1,001 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 12-May-2025.
Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 4/21/2021. The price target of $286.67 was fulfilled within 1 day with a profit of $10.46 (3.52%) receiving and performance score of 35.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$87.4
10 days ago
(20-May-2025)
3/3 (100%)
$19.88 (29.44%)
386
Buy
$99
$12.48 (14.42%)
$106
16 days ago
(14-May-2025)
8/11 (72.73%)
$11.76 (13.48%)
108
Buy
$110
$23.48 (27.14%)
$110
16 days ago
(14-May-2025)
15/26 (57.69%)
$22.76 (26.09%)
393
Buy
$120
$33.48 (38.70%)
$105
2 months 2 days ago
(28-Mar-2025)
8/10 (80%)
$24.23 (25.30%)
338
Buy
$108
$21.48 (24.83%)
$110
3 months 3 days ago
(27-Feb-2025)
7/10 (70%)
$16.03 (17.43%)
282
Which stock is Richard Newitter is most bullish on?
Which stock is Richard Newitter is most reserved on?
What Year was the first public recommendation made by Richard Newitter?